Pyelonephritis acute

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Allecra Therapeutics Commercial
    CEFEPIME, ENMETAZOBACTAM
    2024-518003-22-00 6 countries 2023 n=30
    Halted
  • Menarini Ricerche S.p.A. Commercial
    MEROPENEM, VABORBACTAM
    2024-514656-32-00 5 countries 2025 n=44
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Allecra Therapeutics Commercial 1 Phase II 0
Menarini Ricerche S.p.A. Commercial 1 Phase II 1
New trials by year
2023
1
2025
1
← All indication landscapes